Congress should follow science and reject Bayer push to block lawsuits
By Nathan Donley
Millions of American users of glyphosate-based Roundup have likely assumed the Environmental Protection Agency (EPA) would never have approved the pesticide unless it was safe.
But the science-based truth has never been as cut and dried as the EPA and Bayer, which bought Roundup maker Monsanto in 2018, have made it sound. In a series of trials across the country, juries – and the public – have learned that despite the safety claims by Bayer and the EPA, hundreds of studies by independent scientists link glyphosate herbicides to serious health harms, including cancer.
Even though Bayer maintains that its glyphosate products are safe and not carcinogenic, the company has thus far agreed to pay out more than $10 billion in settlement costs to tens of thousands of glyphosate users suffering from non-Hodgkin lymphoma (NHL), and thousands of lawsuits remain.
In an effort to block further litigation, the chemical giant has turned its focus to getting federal and state legislation passed to block Roundup users from suing the company for damages. According to a recent Washington Post article, Bayer helped draft language for a legislative measure that would limit the types of lawsuits brought by the Roundup users. That measure is included in the US House of Representatives version of the 2024 Farm Bill, which is slated to be finalized later this year. The company has also been pushing lawmakers in several states to pass similar measures.
Key to Bayer’s messaging to legislators is that, because glyphosate is EPA-approved, research showing its harms should be rejected. But the process by which the EPA approved glyphosate decades ago has never been reassuring to independent scientists such as myself.